These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27446399)

  • 1. Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.
    Luo G; Zhou Y; Yi W; Yi H
    Oncol Lett; 2016 Aug; 12(2):1085-1094. PubMed ID: 27446399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of nasopharyngeal carcinoma associated with polymorphic lactotransferrin haplotypes.
    Zhou Y; Wang W; Zheng D; Peng S; Xiong W; Ma J; Zeng Z; Wu M; Zhou M; Xiang J; Xiang B; Li X; Li X; Li G
    Med Oncol; 2012 Sep; 29(3):1456-62. PubMed ID: 22011934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of haplotype in lactotransferrin and its expression levels in Chinese Han ovarian cancer.
    Cao L; Zhou Y; Li X; Yi H
    Acta Biochim Biophys Sin (Shanghai); 2011 Nov; 43(11):884-90. PubMed ID: 21937479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactotransferrin expression is downregulated and affects the mitogen-activated protein kinase pathway in gastric cancer.
    Luo G; Zhou Y; Yi W; Yi H
    Oncol Lett; 2015 May; 9(5):2409-2413. PubMed ID: 26137081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.
    Zhou Y; Zeng Z; Zhang W; Xiong W; Wu M; Tan Y; Yi W; Xiao L; Li X; Huang C; Cao L; Tang K; Li X; Shen S; Li G
    Int J Cancer; 2008 Nov; 123(9):2065-72. PubMed ID: 18697201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms.
    Deng M; Zhang W; Tang H; Ye Q; Liao Q; Zhou Y; Wu M; Xiong W; Zheng Y; Guo X; Qin Z; He W; Zhou M; Xiang J; Li X; Ma J; Li G
    Oncogene; 2013 Sep; 32(36):4273-83. PubMed ID: 23069661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma.
    Yi HM; Li H; Peng D; Zhang HJ; Wang L; Zhao M; Yao KT; Ren CP
    Oncol Res; 2006; 16(6):261-72. PubMed ID: 17476971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
    Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
    Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression, genetic and epigenetic alterations of LTF gene in nasopharyngeal carcinoma cell lines].
    Yi HM; Li YC; Zhong RH
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):729-33. PubMed ID: 21163060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines.
    Zhang H; Feng X; Liu W; Jiang X; Shan W; Huang C; Yi H; Zhu B; Zhou W; Wang L; Liu C; Zhang L; Jia W; Huang W; Li G; Shi J; Wanggou S; Yao K; Ren C
    J Cell Biochem; 2011 Jul; 112(7):1832-43. PubMed ID: 21400573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma.
    Wang G; Jiang H; Xu H; Sun Q; Zhou Y; Xiang P; Cheng Z; Zhang Y; Zhou Y; Guo Q; DU X; Xu S; Ma S; Chen Z
    Oncol Lett; 2015 Apr; 9(4):1681-1686. PubMed ID: 25789023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network.
    Zhang L; Deng T; Li X; Liu H; Zhou H; Ma J; Wu M; Zhou M; Shen S; Li X; Niu Z; Zhang W; Shi L; Xiang B; Lu J; Wang L; Li D; Tang H; Li G
    Carcinogenesis; 2010 Apr; 31(4):559-66. PubMed ID: 20053927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA Expression Profiles in Nasopharyngeal Carcinoma by Sequence Analysis.
    Yang J; Gong Y; Jiang Q; Liu L; Li S; Zhou Q; Huang F; Liu Z
    Front Oncol; 2020; 10():601. PubMed ID: 32426279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
    Yin W; Shi L; Mao Y
    J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
    Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
    Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma.
    Yue PY; Ha WY; Lau CC; Cheung FM; Lee AW; Ng WT; Ngan RK; Yau CC; Kwong DL; Lung HL; Mak NK; Lung ML; Wong RN
    Sci Rep; 2017 Sep; 7(1):12012. PubMed ID: 28931826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.